Clinical Trials Browser

Phase EARLY_PHASE1 × Breast Neoplasms × Bortezomib × Clear all

NCT04265872 2026-02-12

Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBC

Phase EARLY_PHASE1 Recruiting

Breast Neoplasms